Viremia: all 57 studies
Page 1 of 1. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- 25BT056: Basket Study of Viral Cytotoxic T LymphocytesNot yet recruitingNCT07873970Early Phase 1
- Adaptability of an Undetectable = Untransmissible Model for HBVRecruitingNCT07449091
- EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell TransplantationRecruitingNCT07438067Phase 1
- Safety, Virological and Immunological Assessment of the Controlled Dengue Human Infection Model in Dengue-Immune Participants in Thailand (DHIT-Immune)Not yet recruitingNCT06908018Early Phase 1
- Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in TanzaniaRecruitingNCT06605053Not applicable
- Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial SepsisRecruitingNCT06491966
- Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)RecruitingNCT06341543Not applicable
- Expansion of Virus-Specific Lymphocytes for Cell TherapyRecruitingNCT06011486Phase 1
- Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant RecipientsRecruitingNCT05432778Phase 2
- Optimizing a Bio-behavioral Intervention for Sustained Viral SuppressionRecruitingNCT05377463Not applicable
- Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) PatientsRecruitingNCT04887623
- PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)RecruitingNCT03729752Phase 1
- Enhanced Virologic Monitoring for Pregnant and Postpartum Women With HIVCompletedNCT05845619Not applicableResults posted
- Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent VaccineCompletedNCT05691530Phase 1Results posted
- Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation TrialCompletedNCT03374202Phase 1Results posted
- Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV InfectionCompletedNCT02384395Not applicableResults posted
- BK Virus Infection (Viremia) Natural History in Renal Transplant RecipientsCompletedNCT01782209Results posted
- Using mTOR Inhibitors in the Prevention of BK NephropathyCompletedNCT01649609Not applicableResults posted
- Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated MalignanciesCompletedNCT01498484Phase 2Results posted
- Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to RecipientsCompletedNCT01329185Phase 2Results posted
- BK Treatment StudyCompletedNCT01034176Phase 4Results posted
- Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy AdultsCompletedNCT00442169Phase 2Results posted
- Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral TherapyCompletedNCT00367458Phase 2Results posted
- PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDYActive, not recruitingNCT07021092Not applicable
- CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary ImmunodeficiencyActive, not recruitingNCT07015801Not applicable
- Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIVCompletedNCT06999928Not applicable
- Clinical Performance Evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Immunocompromised Transplant PatientsCompletedNCT06681025
- Long Acting Cabotegravir Plus Rilpivirine in People Living With HIV-1 Aged ≥ 60 Years for 24 Months.Active, not recruitingNCT06646562Phase 4
- Differentiated Service Delivery for Pregnant and Postpartum Women Living With HIV and Their InfantsCompletedNCT06629753Not applicable
- Metagenomic Sequencing for the Identification of Pathogens in Febrile Neutropenic PatientsTerminatedNCT06075888Not applicable
- Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived InfectionsStatus unknownNCT05799716Phase 4
- Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant RecipientsCompletedNCT05769582Phase 2/3
- The Immunostimulatory Effects of GentamicinTerminatedNCT05303909Phase 2
- Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low ViremiaStatus unknownNCT05203055Phase 1/2
- Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and DiabetesCompletedNCT04769167Not applicable
- Convalescent Plasma for Treatment of COVID-19CompletedNCT04649879Phase 2/3
- CMV Infection and Immune Intervention After TransplantationStatus unknownNCT04320303Not applicable
- The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in HumanStatus unknownNCT04298502
- Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical TransmissionStatus unknownNCT03476083Phase 4
- Validation of a Proteomic Signature and Assessment of Viremia in Children With Fever Without SourceCompletedNCT03224026
- Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCVCompletedNCT02690103Phase 2
- Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)TerminatedNCT02247687Phase 3
- CMV Glycoprotein B (gB) Vaccine Long Term Antibody ResponseCompletedNCT01883206
- Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B VirusCompletedNCT01788371Phase 4
- An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK ViruriaTerminatedNCT01620268Phase 2
- Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B VirusCompletedNCT01488526Phase 4
- Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)CompletedNCT00947141Phase 4
- BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)TerminatedNCT00414284Phase 4
- Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)CompletedNCT00285259Phase 2
- Yellow Fever Virus Vaccine and Immune Globulin StudyCompletedNCT00254826Phase 1
- HIV in Specific Parts of the Body of Patients Who Are Changing or Starting Potent Anti-HIV DrugsCompletedNCT00007488
- Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIVCompletedNCT00006145Phase 3
- Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive PatientsCompletedNCT00001131Not applicable
- Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected PatientsCompletedNCT00001110Not applicable
- A Study to Monitor Patients With Primary or Early HIV InfectionCompletedNCT00000911
- The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One YearCompletedNCT00000848Phase 2
- A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNACompletedNCT00000840